AREV Life Sciences Global Corp. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CAD 0.023089 million compared to CAD 0.026483 million a year ago. Net loss was CAD 0.24065 million compared to CAD 0.219914 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the nine months, sales was CAD 0.041904 million compared to CAD 0.113011 million a year ago. Net loss was CAD 1.52 million compared to CAD 1.49 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.06 a year ago.